CatapultCrown | Magdent
Header
logo

Magdent

Startup logo
Startup logo

Investment ID: Catapult Crown 2

Startup image
Startup image
play button

Secure your allocation in Magdent today!

Investment Overview

Investment Overview

The $4B dental implantation industry suffers from three main challenges[1]:  

  1. A long healing process, which ranges from 3-6 months, and up to 9 months in cases of bone grafts.
  2. Failure with high-risk patients, mostly due to poor bone quality.
  3. Peri-implant Mucositis / Peri-implantitis which appears in around 34% of cases.

Magdent’s groundbreaking Miniaturized Electromagnetic Device (MED) utilizes Pulsed Electro-Magnetic Fields (PEMF) which offers a potential solution to all three of these challenges. The MED can be inserted into up to 85% of implant brands and models and has the potential to (i) be used as an adjunct therapy for treatment of peri-implantitis, growing bone in inflammatory conditions; (ii) accelerate bone growth (osseogenesis) and thus reduce the healing period from 3-6 months to 1-2 months; and (iii) improve implantation success chances in high-risk patients by improving bone quality, increasing bone-to-implant contact and the trabecular bone volume density.

With its CE mark certification (FDA approval in progress), Magdent is rapidly expanding and partnering with dental implant companies and DSOs, delivering innovative technology across Europe and globally. As we grow, we are broadening our product portfolio and continuing our research, focusing on treating and preventing peri-implant diseases and exploring the effects of PEMF on bone grafting.

Funding Target

$ 2,000,000

Company Highlights

Join or Sign in to view the details

Team

Join or Sign in to view the details

Why We Have Selected Magdent

Join or Sign in to view the details

Analysis

Join or Sign in to view the details

Presentation

Join or Sign in to view the details

Webinars And Videos

Magdent